IL-24 is the key effector of Th9 cell-mediated tumor immunotherapy
Summary: Th9 cells are powerful effector T cells for cancer immunotherapy. However, the underlying antitumor mechanism of Th9 cells still needs to be further elucidated. Here, we show that Th9 cells express high levels of not only IL-9, but also IL-24. We found that knockout of Il24 gene in Th9 cell...
Main Authors: | Jintong Chen, Yunwei Zhang, Hua Zhang, Mingyue Zhang, He Dong, Tianxue Qin, Sujun Gao, Siqing Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004223016085 |
Similar Items
-
Autonomous IL-36R signaling in neutrophils activates potent antitumor effector functions
by: Sumedha Roy, et al.
Published: (2023-06-01) -
Overcoming lung cancer immunotherapy resistance by combining nontoxic variants of IL-12 and IL-2
by: Brendan L. Horton, et al.
Published: (2023-10-01) -
IL-21–producing effector Tfh cells promote B cell alloimmunity in lymph nodes and kidney allografts
by: Hengcheng Zhang, et al.
Published: (2023-10-01) -
The small intestine epithelium exempts Foxp3+ Tregs from their IL-2 requirement for homeostasis and effector function
by: Praveen Prakhar, et al.
Published: (2021-11-01) -
Mammary γδ T cells promote IL-17A-mediated immunity against Staphylococcus aureus-induced mastitis in a microbiota-dependent manner
by: Na Pan, et al.
Published: (2023-12-01)